Lake Street Maintains Buy on Biodesix, Lowers Price Target to $30
Benzinga Newsdesk 16 hours ago
Analyst RatingsNewsPrice Target
Lake Street analyst Thomas Flaten maintains Biodesix (NASDAQ:BDSX) with a Buy and lowers the price target from $40 to $30.
Lake Street analyst Thomas Flaten maintains Biodesix (NASDAQ:BDSX) with a Buy and lowers the price target from $40 to $30.